Tower Research Capital (TRC)’s Fractyl Health GUTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,768	Closed	-$32.5K	–	5640
2025 Q4	$32.5K	Buy	14,768 +9,559	+184%	+$15.4K	﹤0.01%	2749
2025 Q3	$8.28K	Buy	5,209 +2,414	+86%	+$3.13K	﹤0.01%	4053
2025 Q2	$4.53K	Sell	2,795 -5,509	-66%	-$8.9K	﹤0.01%	4312
2025 Q1	$9.88K	Buy	8,304 +2,694	+48%	+$4.3K	﹤0.01%	3710
2024 Q4	$11.6K	Buy	5,610 +862	+18%	+$2.01K	﹤0.01%	3699
2024 Q3	$12K	Buy	4,748 +3,656	+335%	+$11.9K	﹤0.01%	3628
2024 Q2	$4.66K	Sell	1,092 -4,357	-80%	-$28K	﹤0.01%	4752
2024 Q1	$40.3K	Buy	+5,449	New	+$45.9K	﹤0.01%	2422

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s GUTS Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 14,768 shares — an estimated $32.5K sold.

Tower Research Capital (TRC) first reported a position in GUTS in Q1 2024 and held it in 8 quarters. The position peaked at $40.3K in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 14,768 Fractyl Health shares in Q1 2026, an estimated $32.5K.
Tower Research Capital (TRC) first reported a position in Fractyl Health in Q1 2024 and held it in 8 quarters.
Tower Research Capital (TRC)'s Fractyl Health position peaked at $40.3K in Q1 2024.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.